Ocuserts: A novel ocular drug delivery system
Abstract
Ocular drug delivery poses significant challenges due to the unique anatomy and physiology of the eye. Conventional dosage forms, such as eye drops, often suffer from poor bioavailability, short residence time, and frequent dosing. To overcome these limitations, ocular inserts have emerged as a promising solution. These inserts provide sustained and controlled drug release, increasing the contact time with the ocular surface and enhancing bioavailability. This review discusses the advantages and disadvantages of ocular inserts, their classification, mechanism of drug release, formulation methods, and evaluation parameters. Ocular inserts offer several benefits, including improved patient compliance, reduced dosing frequency, and increased therapeutic efficacy.
Keywords: Eye, Ocuserts, Controlled release, Corneal contact, Bioavailability
Keywords:
Eye, Ocuserts, Controlled release, Corneal contact, BioavailabilityDOI
https://doi.org/10.22270/jddt.v15i6.7229References
1. Devhadrao V, Siddhaia M. Review on ocular insert drug delivery system. Journal of Drug Delivery & Therapeutics. 2018; 8(5-s):115-121. https://doi.org/10.22270/jddt.v8i5-s.1991
2. Nagpal N, Singh S, Kaur G, Kaur P, Dhawan RK, Chhina MS, Arora M. Formulation and evaluation of controlled release ocusert of gatifloxacin and prednisolone. Acta Marisiensis-Seria Medica. 2021 Oct 18;67(4): 227-37. https://doi.org/10.2478/amma-2021-0032
3. Karthikeyan D, Bhowmick M, Pandey VP, Nandhakumar J, Sengottuvelu S, Sonkar S, Sivakumar T. The concept of ocular inserts as drug delivery systems: An overview. Asian Journal of Pharmaceutics (AJP). 2008;2(4). 115-21. https://doi.org/10.4103/0973-8398.45031
4. Vyas U, Gehlot N, Jain V, Mahajan SC. A Review on In Situ Gelling System for Ophthalmic Drug Delivery, Current research in pharmaceutical sciences. 2021;11(4):98-106. https://doi.org/10.24092/CRPS.2021.110402
5. Dwivedi P, Chand P, Gnanarajan G, Kotiyal P. Review on ocular inserts. World Journal of Pharmaceutical Research. 2015;4(11):493-523. https://doi.org/10.30750/ijpbr.4.2.2
6. Kumar BP, Harish G, Bhowmik D. Ocular inserts: A novel controlled drug delivery system. The Pharma Innovation. 2013 Feb 1;1(12):1-16.
7. Kurade D, Joshi D, Bandgar A. A review on ocular drug delivery with new trends. International Journal of Advanced Research. 2015;3(11):629 - 642.
8. Sharma D, Tyagi S, Kumar B. Novel approaches of treatment via ocusert drug delivery. Asian Journal of Nanoscience and Materials. 2019;356-366.
9. Dabral K, Uniyal Y. Ocular inserts: Novel approach for drug delivery into eyes. GSC Biological and Pharmaceutical Sciences, 2019;07(03):001-007.
https://doi.org/10.30574/gscbps.2019.7.3.0087
10. Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: An overview. World journal of pharmacology. 2013 ;9;2(2):47-64 https://doi.org/10.5497/wjp.v2.i2.47 PMid:25590022 PMCid:PMC4289909
11. Ghate D, Edelhauser HF. Ocular drug delivery. Expert opinion on drug delivery. 2006 ;1;3(2):275-287. https://doi.org/10.1517/17425247.3.2.275 PMid:16506953
12. Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, Singhvi G. Nanocarriers for ocular drug delivery: Current status and translational opportunity. RSC advances. 2020;10(46):27835-55. https://doi.org/10.1039/D0RA04971A PMid:35516960 PMCid:PMC9055630
13. Das P, Vigneshwaran L, Thaisena F. Review article of ocuserts. International Journal of Research Publication and Reviews, 2024;5(2):90-97.
14. Sandle T. Sterile ophthalmic preparations and contamination control. Journal of GXP Compliance. 2014;18:1-5.
15. Kumar K., Singh L. Review article on ocusert: a novel ophthalmic drug delivery system. Journal of Emerging Technologies and Innovative Research. 2014;1(3): 1221-1229.
16. Venkateswara S, Rao, Tejaswi BCD, Anusha A, Padmalatha K. Fluconazole ocuserts: formulation and evaluation. Journal of Pharmaceitical Science and Research. 2018;10(1): 26-30.
17. Mirzaeeia S, Alizadehc M. Design and evaluation of soluble ocular insert for controlled release of chloramphenicol. Journal of Reports in Pharmaceutical Science. 2017;6(2):123-133. https://doi.org/10.4103/2322-1232.222620
18. Patel A, Cholkar K, Agrahari V, Mitra A. Ocular drug delivery systems: An overview. World J Pharmacol. 2013;2(2): 47-64. https://doi.org/10.5497/wjp.v2.i2.47 PMid:25590022 PMCid:PMC4289909
19. Stevenson CL, Santini Jr JT, Langer R. Reservoir-based drug delivery systems utilizing microtechnology. Advanced drug delivery reviews. 2012 Nov 1;64(14):1590-602. https://doi.org/10.1016/j.addr.2012.02.005 PMid:22465783 PMCid:PMC3430809
20. Kumar K, Singh L. Review Article on Ocusert: A Novel Ophthalmic Drug Delivery System. Journal of Emerging Technologies and Innovative Research. 2014;1(3):1221-9.
21. Mishra DN, Gilhotra RM. Design and characterization of bioadhesive in-situ gelling ocular inserts of gatifloxacin sesquihydrate. DARU Journal of Pharmaceutical Sciences, 2008;16(1):1-8.
22. Nagpal N, Singh S, Ahad P, Chhina M, Arora M, Kaur D, Kumar R, Sharma A, Kumar N. Ocuserts: A novel ocular-drug delivery method: An update. World Journal of Biology Pharmacy and Health Sciences, 2023;13(01):470-477. https://doi.org/10.30574/wjbphs.2023.13.1.0025
23. Banu S, Farheen SA. Ocular Drug Delivery System: A Novel Approach. Asian Journal of Research in Pharmaceutical Science. 2019;9(2): 97-106. https://doi.org/10.5958/2231-5659.2019.00015.8
24. Pawar S, Ranbawale H, Rathod G, Suryawanshi S. Ocusert: a novel opthalmic drug delivery system. International Journal of Current Science. 2024;14(2):1-16.
25. Rajesh A, Poonam D, Sangeeta A. Ocular drug delivery system: ocular insert. International Journal of Universal Pharmacy and Bio Sciences. 2012;1(2):30-8. https://doi.org/10.1201/b12950-28
26. Kumar BP, Harish G, Bhowmik D. Ocular inserts: A novel controlled drug delivery system. Pharma Innovation. 2013 Feb 1;1(12):1-16.
27. Saettone MF. Progress and problems in ophthalmic drug delivery. Business Briefing: Pharmatech. 2002; 1:167-71.
28. Karthikeyan D, Bhowmick M, Pandey V, Nandhakumar J, Sengottuvelu S, Sonkar S, Thangavel S. The concept of ocular inserts as drug delivery systems: An overview. Asian Journal of Pharmaceutics. 2008;192-200. https://doi.org/10.4103/0973-8398.45031
29. Bindod HV, Hatwar PR and Bakal RL. Innovative ocular drug delivery systems: A comprehensive review of nano formulations and future directions. GSC Biological and Pharmaceutical Sciences, 2024; 29(02): 163-177. https://doi.org/10.30574/gscbps.2024.29.2.0422
30. Sahane NK, Banerjee SK, Gaikwad DD, Jadhav SL, Throat RM. Ocular inserts: a review. Drug Invention Today. 2010 Jan;2(1):57-64.
31. Menqi SA, Controlled and Novel Drug Delivery Systems. CBS Publishers, 2004: P. 82-96.
32. Hajare A, Mali S, Salunke S, Nadaf S, Bhatia N, Bagal P, Gaikwad S, Pawar K. A rational approach to ocular drug delivery systems: A overview. WJPR. 2014 Jan 6;3(2):3324-48.
33. Kitukale SR, Yeole KG, Bakal RL, Hatwar PR, Chakare SY. Ocular Drug Delivery System. International Journal of Research and Analytical Review. 2023; 10(2), 280-285.
34. Preeti K, Jain R, Choukse R, Dubey PK, Agrawal S. Ocusert as a novel drug delivery system. Int. J. Pharm. Biol. Arch. 2013; 4:614-9.
35. Karki S, Kim H, Na SJ, Shin D, Jo K, Lee J. Thin films as an emerging platform for drug delivery. Asian journal of pharmaceutical sciences. 2016 Oct 1;11(5):559-74. https://doi.org/10.1016/j.ajps.2016.05.004
36. Tanwar, Y., D. Patel, And S. Sisodia, In Vitro And In Vivo Evaluation Of Ocular Inserts of Ofloxacin. DARU, 2007: P. 139-45.
37. Patel UL, Chotai NP, Nagda CD. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation. Pharmaceutical Development and Technology. 2012 Feb 1;17(1):15-22. https://doi.org/10.3109/10837450.2010.502178 PMid:20649410
38. Mathurm M, Gilhotra RM. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E2-induced ocular inflammation. Drug delivery. 2011 Jan 1;18(1):54-64. https://doi.org/10.3109/10717544.2010.509366 PMid:20718601
39. Sankar V, Chandrasekaran AK, Durga S, Geetha G, Ravichandran V, Vijayakumar A, Raguraman S. Design and evaluation of diclofenac sodium ophthalmic inserts. Acta Pharmaceutica Sciencia. 2006;48(1). 5-10.
40. Saroot R, Gilhotra RM. Design and characterization of bioadhesive ophthalmic films of flurbiprofen. The Thai Journal of Pharmaceutical Sciences. 2011;35(1):29-39. https://doi.org/10.56808/3027-7922.2150
41. Charoo NA, Kohli K, Ali A, Anwer A. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies. Drug development and industrial pharmacy. 2003 Jan 1;29(2):215-21. https://doi.org/10.1081/DDC-120016729 PMid:12648018
42. Chandran S, Roy A, Saha RN. Effect of pH and formulation variables on in vitro transcorneal permeability of flurbiprofen: a technical note. Aaps Pharmscitech. 2008;9:1031-7. https://doi.org/10.1208/s12249-008-9139-4 PMid:18792792 PMCid:PMC2977025
43. Watmode DS, Hatwar PR, Bakal RL and Rom MV, A Review on eye drop. World Journal of Pharmaceutical Research. 2023; 12(21), 1298-1306.
44. Kriti D, Yashika U. Ocular inserts: Novel approach for drug delivery into eyes. GSC Biological and Pharmaceutical Sciences. 2019;7(3):01-7. https://doi.org/10.30574/gscbps.2019.7.3.0087
Published
Abstract Display: 1435 
PDF Downloads: 774 PDF Downloads: 264 How to Cite
Issue
Section
Copyright (c) 2025 Atharv V. Korde , Kanchan A. Hiwe, Ravindra L. Bakal , Pooja R. Hatwar , Prathmesh S. Sune
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.